undamentalytics Newsletter
Sign in

Heartsciences Inc. balance sheet

At the end of fiscal 2026, Heartsciences Inc. had total assets of $5.3m, total liabilities of $5.0m and shareholders' equity of $226,060. It held $1.7m in cash against $3.6m of debt: net debt of $2.0m.

Balance sheet

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2022Apr 20222023Apr 20232024Apr 20242025Apr 20252026Apr 2026LTMJul 2026
Cash and equivalents9181,6605,8081,1001,65730
Receivables2——4——
Inventory674676629650656403
Total current assets1,9312,6977,3542,1712,583812
Total assets2,0893,2879,5034,2235,2633,737
Accounts payable6956314483193181,023
Total current liabilities3,4711,8331,7523,7034,8615,633
Long-term debt4,4425000000
Total debt6,0721,0005002,5513,6223,723
Total liabilities8,1453,0572,1864,0185,0375,770
Shareholders' equity−6,0562317,317205226−2,033
Net debt (negative = net cash)5,154−660−5,3081,4511,9653,693
Shares outstanding———1m3m4m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CUPR vs HSCSHSCS vs POASHSCS vs PAVM

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Heartsciences Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Heartsciences Inc.